Assessment of health complications associated with methadone use in the general population in France: incidence of hospitalizations and deaths and the role of drug-drug interactions (METHALICA)

Study identification

• EU PAS number:
  EUPAS1000000250
• Study ID:
  1000000250
• Official title and acronym:
  Assessment of health complications associated with methadone use in the general population in France: incidence of hospitalizations and deaths and the role of drug-drug interactions (METHALICA)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

Department of Clinical Pharmacology and Pharmacosurveillance, University Hospital of Marseille

France

Study timelines

Date when funding contract was signed

Actual:03/11/2023

Study start date

Planned:01/01/2024

Date of final study report

Planned:31/12/2025

Sources of funding

National competent authority (NCAs)

More details on funding

EPI-PHARE/ANSM

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable